Sleep & Recovery

Purpose

Scope

Requirements

• Supporting healthy sleep is not the same as diagnosing or treating a sleep disorder. Professionals must distinguish general sleep education, individualized non-medical support and clinical diagnosis or treatment, and act within their actual scope.
• Sleep need and appropriate sleep timing may vary between individuals and life stages. Population guidance may inform professional practice, but must not automatically be treated as an individual optimum, diagnostic target or evidence of a sleep disorder.
• Sleep duration alone is not a complete measure of sleep quality, functional sleep outcomes or recovery. Timing, regularity, continuity, subjective restoration, daytime function and context may also matter.
• Short-term poor sleep or isolated unusual nights must not be presented without sufficient context as a sleep disorder, hormonal dysfunction, neurological problem or other diagnosis.
• Persistent or relevant sleep problems, marked persistent daytime sleepiness, observed breathing pauses or repeated gasping during sleep, recurring unusual nocturnal behaviors, major sleep problems with substantial daytime impairment, sudden or safety-relevant tendency to fall asleep, or other red flags must not be dismissed through optimization strategies alone. Red flag ≠ diagnosis. Where appropriate professional assessment is outside scope, referral is required.
• Professionals must treat fatigue, sleepiness and subjectively low recovery as related but non-identical concepts. Sleepiness, fatigue and low recovery are related signals, not interchangeable diagnoses. A single recovery indicator does not establish a specific cause.
• Consumer sleep scores, wearables and algorithmic recovery scores must be interpreted in accordance with H-03 Wearables & Consumer Health Technology. Displayed precision is not automatically clinical accuracy.
• Consumer sleep data may be useful for education, monitoring or trend observation without thereby becoming a clinical sleep study or diagnosis.
• Consumer sleep-stage estimates must not be treated as equivalent to polysomnographic sleep staging unless specifically validated for that use.
• Individual wearable nights and trends must be distinguished. Trends are meaningfully interpretable only where the device, algorithm and relevant conditions of use are sufficiently comparable.
• Changes to device, firmware, algorithm or scoring model may alter comparability of sleep and recovery data. Validation belongs to a defined version and context, not to a product name forever.
• Sleep-related health claims must comply with H-01 Health Information & Claims and U-03 Evidence & Scientific Communication. Claim strength must not exceed evidence strength.
• Improvements in a sleep score, HRV value or other recovery marker must not automatically be communicated as demonstrated improvement in a clinical outcome. A higher sleep score is not automatically evidence of improved sleep architecture. A better marker is not automatically a better outcome.
• Circadian-related recommendations should appropriately consider light, timing, daily life, work schedules, travel, shift work and individual circumstances. A single idealized daily rhythm must not be presented as universally appropriate. Recommendations should distinguish biological principles from what is realistically achievable within work and life constraints.
• Sleep restriction must not be presented as a harmless performance strategy. Cumulative sleep curtailment may affect risk, daytime function and performance.
• Professionals must consider that marked fatigue or sleepiness may impair safety during driving, machinery use, training and other risk-relevant activities. Safety takes priority over optimization when sleepiness may impair alertness in risk-critical activities.
• Recovery is a functional concept, not a single biomarker or score. Recovery must be considered in the context of total load. Sleep, exercise, energy availability, stress, illness, travel, heat, cold, alcohol, medications and other factors may jointly affect the recovery profile. Assess the stack, not only the parts.
• Sleep-related supplements and related interventions must also comply with H-04 Supplements & Nutritional Interventions. “Natural” or freely available does not automatically mean appropriate or safe.
• Professionals may individualize non-medical sleep and recovery strategies only to the extent supported by competence, role, applicable rules and context.
• Sedation is not automatically restorative sleep. An intervention that produces short-term sedation, fatigue or subjective sleepiness must not automatically be presented as improving sleep quality, sleep architecture or recovery.
• For new, experimental or insufficiently validated sleep or recovery interventions, evidence gaps and uncertainty must be communicated transparently; H-12 Emerging & Experimental Health Interventions also applies where relevant.
• Monitoring should be proportionate to the intervention and risk. Where new symptoms, substantial deterioration, relevant adverse responses or red flags occur, Modify, Refer or Stop are legitimate professional decisions depending on the situation.
• Where possible acute danger is present, IHPSO Referral Levels and local emergency procedures apply. H-06 does not constitute medical triage.
• Where an IHPSO Evidence Classification is used, it must apply to a specific Sleep, Recovery, Circadian or Outcome claim and must not be assigned broadly to an entire intervention.